Being a non-invasive blood-based test, Trucheck™ can minimize the need to visit a healthcare centre – since the blood sample can also be collected from the privacy and comfort of your home.
Advantages to the individuals:
Advantages to the system:
Individuals with Type 2 diabetes are twice as likely to be diagnosed with pancreatic or liver cancers as compared to those without Type 2 diabetes. These individuals are also at a higher risk of other cancers such as those of the gallbladder, kidney, bladder and colorectum. These risks have prompted physicians to consider the value of cancer screening for people with diabetes. Studies have shown that early detection of cancer improves survival rates. Trucheck™-DM is a blood-based test that can enable early cancer detection. Trucheck™ - Diabetes is a non-invasive blood test that is intended to be used for the detection of cancers of the Liver, Gallbladder, Pancreas, Kidney, Bladder and Colon in males and females with recently diagnosed or existing Type 2 diabetes.
Trucheck™ - Diabetes is a blood test that can detect 6 types of cancer. Trucheck™ - Diabetes is totally non-invasive, radiation free and can be availed from the comfort of your office or home. Trucheck™ - Diabetes is intended to be performed annually as a routine test.
Trucheck™ - Diabetes can help in early detection of cancers that originate in the Liver, Gallbladder, Pancreas, Kidney, Bladder and Colorectum
The Development of Trucheck™ - Diabetes includes extensive Analytical and Clinical validation studies to establish its Accuracy and Reliability.
Trucheck™ - Diabetes has been clinically proven to have accuracy of > 90% in detecting these cancers early.
Ask Your Doctor
Our patient's downloadable content has all the information you and your doctor need to discuss Trucheck™ testing.
